
Cannara Biotech Inc.
Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026

Cannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
Vireo Growth forms partnership with Ace Venture of NY
Simply Solventless Provides Restructuring Update, Including Expected Timing, and Announces Management Change
Vireo Growth Inc. Partners with Ace Ventures to Establish New York's First Minority-owned Vertically Integrated Medical Cannabis Operator
Cresco Labs receives Texas medical cannabis licence
Cresco Labs Awarded Texas Medical Cannabis License
Vencanna Announces Interim Financial Results and Corporate Update for the Three- and Nine-Months ending January 31, 2026
Red Light to support Carhart-Harris Lab for study
Stickit's Ben-Haroosh resigns as CEO
Avicanna omits 2025 net P&L in NR, talks revenue
Green Thumb amends brand licensing deals with Rythm
High Tide Subsidiary NuLeaf Naturals Pursues Participation in U.S. Medicare CBD Pilot Launching Today
Vireo Growth Inc. Announces Closing of Acquisition of Eaze Inc.
Avicanna Reports Full Year 2025 Audited Financial Statements